|
🐜
|
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
42 auth.
E. Ashley,
F. Aweeka,
K. Barnes,
Q. Bassat,
S. Borrmann,
P. Dahal,
Tme Davis,
P. Deloron,
M. B. Denis,
A. Djimde,
J. Faucher,
B. Genton,
P. Guérin,
K. Hamed,
E. Hodel,
...
Liusheng Huang,
Jullien,
H. Karunajeewa,
Kiechel,
P. Kofoed,
G. Lefèvre,
N. Lindegårdh,
K. Marsh,
A. Mårtensson,
M. Mayxay,
R. McGready,
C. Moreira,
P. Newton,
B. Ngasala,
F. Nosten,
C. Nsanzabana,
S. Parikh,
R. Price,
P. Ringwald,
L. Rombo,
B. Schramm,
C. Sibley,
K. Stepniewska,
J. Ursing,
M. Vugt,
N. White,
L. Workman
|
8 |
2015 |
8
🐜
|
|
🐜
|
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
68 auth.
M. Venkatesan,
N. Gadalla,
K. Stepniewska,
P. Dahal,
C. Nsanzabana,
Clarissa Moriera,
R. Price,
A. Mårtensson,
P. Rosenthal,
G. Dorsey,
C. Sutherland,
P. Guérin,
T. Davis,
D. Ménard,
I. Adam,
...
G. Ademowo,
Cesar Arze,
F. N. Baliraine,
N. Berens-Riha,
A. Björkman,
S. Borrmann,
F. Checchi,
M. Desai,
M. Dhorda,
A. Djimde,
B. El-Sayed,
Teferi Eshetu,
Frederick Eyase,
C. Falade,
J. Faucher,
Gabrielle Fröberg,
Anastasia Grivoyannis,
S. Hamour,
S. Houzé,
Jacob D. Johnson,
E. Kamugisha,
S. Kariuki,
J. Kiechel,
F. Kironde,
F. Kironde,
P. Kofoed,
J. Lebras,
M. Malmberg,
M. Malmberg,
L. Mwai,
L. Mwai,
B. Ngasala,
F. Nosten,
S. Nsobya,
A. Nzila,
A. Nzila,
Mary C. Oguike,
S. D. Otienoburu,
B. Ogutu,
J. Ouédraogo,
P. Piola,
P. Piola,
L. Rombo,
B. Schramm,
A. Somé,
J. Thwing,
J. Ursing,
Rina P. M. Wong,
A. Zeynudin,
I. Zongo,
C. Plowe,
C. Sibley,
C. Sibley
|
7 |
2014 |
7
🐜
|
|
🐜
|
Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
12 auth.
J. Achan,
A. Kakuru,
G. Ikilezi,
T. Ruel,
T. Clark,
C. Nsanzabana,
...
E. Charlebois,
F. Aweeka,
G. Dorsey,
P. Rosenthal,
D. Havlir,
M. Kamya
|
6 |
2012 |
6
🐜
|
|
🦁
|
Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
C. Nsanzabana
|
6 |
2019 |
6
🦁
|
|
🐜
|
Impact of Health Research Capacity Strengthening in Low- and Middle-Income Countries: The Case of WHO/TDR Programmes
9 auth.
Happiness Minja,
C. Nsanzabana,
C. Maure,
A. Hoffmann,
S. Rumisha,
Olumide A. T. Ogundahunsi,
...
F. Zicker,
M. Tanner,
P. Launois
|
6 |
2011 |
6
🐜
|
|
🦁
|
Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
C. Nsanzabana,
D. Djallé,
P. Guérin,
D. Ménard,
I. González
|
6 |
2018 |
6
🦁
|
|
🐜
|
Malaria transmission dynamics in central Côte d'Ivoire: the influence of changing patterns of irrigated rice agriculture
13 auth.
B. Koudou,
Y. Tano,
M. Doumbia,
C. Nsanzabana,
G. Cissé,
O. Girardin,
D. Dao,
E. N'Goran,
P. Vounatsou,
G. Bordmann,
...
J. Keiser,
M. Tanner,
J. Utzinger
|
6 |
2005 |
6
🐜
|
|
🐜
|
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
24 auth.
R. Hoglund,
L. Workman,
M. Edstein,
N. Thanh,
N. N. Quang,
I. Zongo,
J. Ouédraogo,
S. Borrmann,
L. Mwai,
C. Nsanzabana,
...
R. Price,
P. Dahal,
N. Sambol,
S. Parikh,
F. Nosten,
E. Ashley,
A. Phyo,
K. Lwin.,
R. McGready,
N. Day,
P. Guérin,
N. White,
K. Barnes,
J. Tarning
|
5 |
2017 |
5
🐜
|
|
🦁
|
In Vitro Activity of Antiretroviral Drugs against Plasmodium falciparum
C. Nsanzabana,
P. Rosenthal
|
5 |
2011 |
5
🦁
|
|
🐜
|
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data
9 auth.
P. Dahal,
U. d’Alessandro,
G. Dorsey,
P. Guérin,
C. Nsanzabana,
R. Price,
...
C. Sibley,
K. Stepniewska,
A. Talisuna
|
5 |
2015 |
5
🐜
|
